Commensalism or Symbiosis: The Potential Use of Rituximab in Steroid-Refractory Evans Syndrome in a Patient With Ulcerative Colitis

Authors

Eyad Ahmed, Department of Internal Medicine, Saint Michael's Medical Center, New York Medical College, Newark, United States.Follow
Kok Hoe Chan, Department of Internal Medicine, Saint Michael's Medical Center, New York Medical College, Newark, United States.
Sindhusha Veeraballi, Department of Internal Medicine, Saint Michael's Medical Center, New York Medical College, Newark, United States.
Theodore Dacosta, Department of Gastroenterology, Saint Michael's Medical Center, New York Medical College, Newark, United States.
Hamid Shaaban, Department of Hematology/Oncology, Saint Michael's Medical Center, New York Medical College, Newark, United States.

Author Type(s)

Faculty, Resident/Fellow

DOI

10.46497/ArchRheumatol.2022.8898

Journal Title

Archives of Rheumatology

First Page

156

Last Page

157

Document Type

Article

Publication Date

3-1-2022

Department

Medicine

Recommended Citation

Ahmed, E., Hoe Chan, K., Veeraballi, S., Dacosta, T., & Shaaban, H. (2022). Commensalism or Symbiosis: The Potential Use of Rituximab in Steroid-Refractory Evans Syndrome in a Patient With Ulcerative Colitis. Archives of Rheumatology, 37 (1), 156-157. https://doi.org/10.46497/ArchRheumatol.2022.8898